Catja Freiburghaus

Company: Hansa Biopharma

Job title: Senior Scientist, Clinical Development Lead Gene Therapy

Seminars:

Evaluating the Risks & Benefits of Immunosuppression in Patients Prior to Gene Therapy Treatment 9:00 am

Tackling pre-existing immunity by utilizing enzymes to cleave IgGs in the blood that exist for the capsid Understanding the optimal time within the treatment phase to dose withb Immunosuppressants Exploring the ability to redose patients after immunosuppression treatmentsRead more

day: Day Two